NEXTRNA THERAPEUTICS
NextRNA Therapeutics creates targeted therapeutics with the aim of discovering novel ncRNAs that cause disease. The company was founded in 2020 and is headquartered in Cambridge, Massachusetts.
NEXTRNA THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Therapeutics
Founded:
2020-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.nextrnatx.com
Total Employee:
11+
Status:
Active
Total Funding:
56.1 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon WordPress Font Awesome Mobile Non Scaleable Content Sitelinks Search Box Euro Yoast WordPress SEO Plugin Yoast SEO Premium
Similar Organizations
Acrivon Therapeutics
Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
METiS Therapeutics
METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.
Remix Therapeutics
Remix Therapeutics is a biotechnology company.
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
Seres Therapeutics
Seres Therapeutics is a microbiome therapeutics company.
Current Advisors List
Current Employees Featured
Founder
Investors List
Evans Capital
Evans Capital investment in Series A - NextRNA Therapeutics
Lightchain Capital
Lightchain Capital investment in Series A - NextRNA Therapeutics
Circle Squared Alternative Investments
Circle Squared Alternative Investments investment in Series A - NextRNA Therapeutics
Cobro Ventures
Cobro Ventures investment in Series A - NextRNA Therapeutics
Jefferies
Jefferies investment in Series A - NextRNA Therapeutics
Rivas Capital
Rivas Capital investment in Series A - NextRNA Therapeutics
Willett Advisors LLC
Willett Advisors LLC investment in Series A - NextRNA Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-08-11 | NextRNA Therapeutics Names Dominique Verhelle as CEO and Expands Leadership Team |
Official Site Inspections
http://www.nextrnatx.com Semrush global rank: 4.54 M Semrush visits lastest month: 2.31 K
- Host name: 151.101.66.159
- IP address: 151.101.66.159
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "NextRNA Therapeutics"
Home - NextRNA
Our proprietary platform, unique capabilities, and deep lncRNA expertise position NextRNA to unlock the vast therapeutic opportunities presented by lncRNAs as a target class. We identify …See details»
About Us - NextRNA
Dysregulated lncRNAs recruit RNA-binding proteins (RBPs) to drive pathological processes across disease areas. Our differentiated therapeutic approach centers on inhibiting the function of pathological lncRNAs by disrupting the interaction …See details»
Our Science - NextRNA
Our proprietary computational engine, NextMAPTM, identifies disease-driving lncRNAs across diseases. We leverage deep lncRNA biology expertise and capabilities to validate the lncRNA …See details»
NextRNA Therapeutics - LinkedIn
NextRNA Therapeutics, Inc. is a Boston-based biotechnology company leading the next revolution of RNA-directed therapeutics. Our focus is on identifying and drugging long non-coding RNAs...See details»
NextRNA Therapeutics - Crunchbase Company Profile …
NextRNA Therapeutics creates targeted therapeutics with the aim of discovering novel ncRNAs that cause disease. The company was founded in 2020 and is headquartered in Cambridge, Massachusetts.See details»
NextRNA Therapeutics Expands Executive Team with Appointment …
Sep 27, 2024 · NextRNA is a biotechnology company focused on developing transformative medicines to address long non-coding RNA (lncRNA)-driven diseases, with a primary focus on …See details»
Bayer and NextRNA Therapeutics enter strategic collaboration to …
Aug 28, 2024 · NextRNA is a biotechnology company focused on developing transformative medicines to address long non-coding RNA (lncRNA)-driven diseases, with a primary focus on …See details»
NextRNA Therapeutics - VentureRadar
Website: https://www.nextrnatx.com Develops therapeutic solutions by unlocking non-coding RNA potential, focusing on long non-coding RNAs, targeting oncology, immunology, and multiple …See details»
NextRNA Therapeutics Expands Executive Team with Appointment …
NextRNA is a biotechnology company focused on developing transformative medicines to address long non-coding RNA (lncRNA)-driven diseases, with a primary focus on oncology and …See details»
NextRNA Therapeutics - Overview, News & Similar companies
Dec 8, 2022 · NextRNA Therapeutics contact info: Phone number: (617) 412-6117 Website: www.nextrnatx.com What does NextRNA Therapeutics do? Founded in 2021, NextRNA is a …See details»
NextRNA Therapeutics Names Dominique Verhelle as …
Aug 11, 2022 · BOSTON-- ( BUSINESS WIRE )-- NextRNA Therapeutics, a biotechnology company unlocking the potential of non-coding RNAs to develop novel and transformative therapeutics, announces the appointment of...See details»
NextRNA Therapeutics Expands Executive Team with Appointment …
Sep 26, 2024 · NextRNA recently announced a multi-year strategic partnership collaboration and license agreement with Bayer to develop small molecule therapeutics targeting lncRNAs in …See details»
NextRNA Launches with $56 Million in Funding to Bring …
Mar 1, 2022 · CAMBRIDGE, Mass.-- ( BUSINESS WIRE )-- NextRNA Therapeutics, a biotechnology company unlocking the potential of non-coding RNAs to develop transformative …See details»
NextRNA Therapeutics, Inc. | Insights
Aug 29, 2024 · Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
Join Us - NextRNA
We are developing transformative medicines to address lncRNA-driven diseases, with a primary focus on oncology and neuroscience. Join a team driven by a common passion to advance …See details»
NextRNA Therapeutics Strengthens Board of Directors with …
BOSTON, September 26, 2023--NextRNA Therapeutics, a biotechnology company unlocking the potential of long non-coding RNAs (lncRNAs) to develop transformative medicines for multiple …See details»
Shana Mendozza - NextRNA
Aug 12, 2024 · Shana Mendozza is the Executive Director of Human Resources at NextRNA, leading all aspects of HR, with a focus on the growth and development of both the people and …See details»
NextRNA Therapeutics · GitHub
RNA sequencing analysis pipeline using STAR, RSEM, HISAT2 or Salmon with gene/isoform counts and extensive quality control. CLIP sequencing analysis pipeline for QC, pre-mapping, …See details»
News & Media - NextRNA
Aug 11, 2022 · Long non-coding RNAs: what’s behind the growing “dark genome” buzz?See details»